» Articles » PMID: 27116935

LIMK Regulates Tumor-Cell Invasion and Matrix Degradation Through Tyrosine Phosphorylation of MT1-MMP

Overview
Journal Sci Rep
Specialty Science
Date 2016 Apr 28
PMID 27116935
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

During their metastatic spread, cancer cells need to remodel the extracellular matrix in order to migrate through stromal compartments adjacent to the primary tumor. Dissemination of breast carcinoma cells is mediated by membrane type 1-matrix metalloproteinase (MT1-MMP/MMP14), the main invadopodial matrix degradative component. Here, we identify MT1-MMP as a novel interacting partner of dual-specificity LIM Kinase-1 and -2 (LIMK1/2), and provide several evidence for phosphorylation of tyrosine Y573 in the cytoplasmic domain of MT1-MMP by LIMK. Phosphorylation of Y573 influences association of F-actin binding protein cortactin to MT1-MMP-positive endosomes and invadopodia formation and matrix degradation. Moreover, we show that LIMK1 regulates cortactin association to MT1-MMP-positive endosomes, while LIMK2 controls invadopodia-associated cortactin. In turn, LIMK1 and LIMK2 are required for MT1-MMP-dependent matrix degradation and cell invasion in a three-dimensional type I collagen environment. This novel link between LIMK1/2 and MT1-MMP may have important consequences for therapeutic control of breast cancer cell invasion.

Citing Articles

LIM kinases in cardiovascular health and disease.

Lateef O, Foote C, Power G, Manrique-Acevedo C, Padilla J, Martinez-Lemus L Front Physiol. 2025; 15():1506356.

PMID: 39744707 PMC: 11688343. DOI: 10.3389/fphys.2024.1506356.


Regulation and signaling of the LIM domain kinases.

Casanova-Sepulveda G, Boggon T Bioessays. 2024; 47(1):e2400184.

PMID: 39361252 PMC: 11663136. DOI: 10.1002/bies.202400184.


The intrinsic substrate specificity of the human tyrosine kinome.

Yaron-Barir T, Joughin B, Huntsman E, Kerelsky A, Cizin D, Cohen B Nature. 2024; 629(8014):1174-1181.

PMID: 38720073 PMC: 11136658. DOI: 10.1038/s41586-024-07407-y.


PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development.

Jiang X, Xu Z, Jiang S, Wang H, Xiao M, Shi Y Cancers (Basel). 2023; 15(20).

PMID: 37894409 PMC: 10605254. DOI: 10.3390/cancers15205042.


Cytoplasmic Tail of MT1-MMP: A Hub of MT1-MMP Regulation and Function.

Strouhalova K, Tolde O, Rosel D, Brabek J Int J Mol Sci. 2023; 24(6).

PMID: 36982142 PMC: 10049710. DOI: 10.3390/ijms24065068.


References
1.
Belkin A, Akimov S, Zaritskaya L, Ratnikov B, Deryugina E, Strongin A . Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem. 2001; 276(21):18415-22. DOI: 10.1074/jbc.M010135200. View

2.
Rosse C, Lodillinsky C, Fuhrmann L, Nourieh M, Monteiro P, Irondelle M . Control of MT1-MMP transport by atypical PKC during breast-cancer progression. Proc Natl Acad Sci U S A. 2014; 111(18):E1872-9. PMC: 4020077. DOI: 10.1073/pnas.1400749111. View

3.
Jiang A, Lehti K, Wang X, Weiss S, Keski-Oja J, Pei D . Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A. 2001; 98(24):13693-8. PMC: 61103. DOI: 10.1073/pnas.241293698. View

4.
Uekita T, Itoh Y, Yana I, Ohno H, Seiki M . Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol. 2002; 155(7):1345-56. PMC: 2199326. DOI: 10.1083/jcb.200108112. View

5.
Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View